Assessing the Effect of TMOD3 on Overall Survival and Progression-Free Survival (PFS) in Ovarian Cancer Patients
55 Views
•
01:53 min
•
August 2nd, 2024
DOI :
August 2nd, 2024
•
57 Views
Dingwen Xu*1, Xiaofei Hu*2, Yang Feng1, Zhihua Lu1, Xianmei Liu3, Huishen Yan1, Jianming Peng1, Sen Luo1, Weijuan Yao4
1Department of Clinic, School of Medicine, Yangzhou Polytechnic College, 2Department of Nuclear Medicine, Huangshi Central Hospital, Affiliated Hospital of Hubei Institute of Technology, 3School of Biology and Engineering, Guizhou Medical University, 4Hemorheology Center, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center
* These authors contributed equally
文字起こし
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved